Characteristics and determinants of sumatriptan-associated chest pain

Archives of Neurology

Volumn 54, Issue 11, 1997, Pages 1387-1392

  Ottervanger, Jan Paul ^a,b   Valkenburg, Hans A ^b   Grobbee, Diederick E ^b,c   Stricker, Bruno H C ^a,b  

^a Netherlands Ctr Monitoring A   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX; SEX DIFFERENCE; THORAX PAIN;

EID: 0030729538     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550230054017     Document Type: Article

References (37)

1. Dechant KL, Clissold SP. Sumatriptan: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1992;43:776-798.
2. Plosker GL, McTavish D. Sumatriptan: a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs. 1994;47:622-651.
3. Ottervanger JP, Stricker BHC. Cardiovascular adverse reactions to Sumatriptan: cause for concern? CTS Drugs. 1995;3:90-98.
4. 1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation. 1993;87:401-405.
5. 1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol. 1992;34:541-546.
6. Palmer J, Feldman R, Mancini GBJ, Zimmerman M. Glyceryl trinitrate reversal of post-sumatriptan coronary artery narrowing. Lancet 1995;345:1366.
7. Kelly KM. Cardiac arrest following use of sumatriptan. Neurology. 1995;45:1211-1213.
8. Willet F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by sub-cutaneous sumatriptan. BMJ. 1992;304:1415.
9. Ottervanger JP, Paalman HJA, Boxma GL, Stricker BHC. Transmural myocardial infarction with sumatriptan. Lancet. 1993;341:861-862.
10. Walton-Shirley M, Flowers K, Whiteside JH. Unstable angina pectoris associated with Imitrex therapy. Cathet Cardiovasc Diagn. 1995;34:188.
11. Weidmann B, Jansen W, Bojko P, Hänseler T, Hinzmann S, Tauchert M. Sumatriptan-induzierter Myokardinfarkt. Intensivmedizin. 1994;31:353.
12. O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology. 1995;45:2274-2276.
13. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache. 1996;36:329-331.
14. Longmore J, Boulanger CM, Desta B, Hill RG, Schofield WN, Taylor AA. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519. Br J Clin Pharmacol. 1996;42:431-441.
15. Brown EG, Endersby CA, Smith RN, Talbot JCC. The safety and tolerability of sumatriptan: an overview. Eur Neurol. 1991;31:339-344.
16. Ottervanger JP, van Witsen TB, Valkenburg HA, Stricker BHC. Postmarketing study of cardiovascular adverse reactions associated with sumatriptan. BMJ. 1993; 307:1185.
17. Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet. 1995;346:923-926.
18. Inman W, Kubota K. Cardiorespiratory distress after sumatriptan given by injection. BMJ. 1992;305:714.
19. Ottervanger JP, Valkenburg HA, Grobbee DE, Stricker BHC. Adverse reactions attributed to sumatriptan: a postmarketing study in general practice. Eur J Clin Pharmacol. 1994;47:305-309.
20. Walma EP, van Dooren C, van der Does E, Prins A, Hoes AW. Accuracy of an automatic oscillometric blood pressure device: the Omron HEM403C. J Hum Hypertens. 1995;9:169-174.
21. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO. 1962;27:645-658.
22. Silman A, Holligan S, Brennan P, Maddison P. Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ. 1990;301:590-592.
23. Hougton LA, Foster JM, Whorwell PJ, Morris J, Fowler P. Is chest pain after sumatriptan oesophageal in origin? Lancet. 1994;344:985-986.
24. Hood S, Brine D, MacIntyre PD, et al. Sumatriptan-induced chest pain. Lancet. 1994;344:1500-1501.
25. Swedish Adverse Drug Audit Committee. Angina Pectoris and Sumatriptan. Uppsala, Sweden; 1994;63:4-5. Bulletin.
26. Blau JN, MacGregor EA. Is abdominal pain a feature of adult migraine? Headache. 1995;35:207-209.
27. MacLean MR, Smith GCS, Templeton AGB. Adverse reactions associated with sumatriptan. Lancet. 1993;341:1092.
28. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
29. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
30. Treasure CB, Manoukian SV, Klein JL, Vita JA, Nabel EG. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992;71:776-781.
31. Treasure CB, Klein JL, Vita JA, et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 1993;87:86-93.
32. Chowienczyk PJ, Watts GF, Cockroft JR, Brett SE, Ritter JM. Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet. 1994; 344:305-306.
33. Chowienczyk PJ, Watts GF, Cockroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430-1432.
34. Nitenberg A, Antony I, Foult J-M. Acetylcholine-induced coronary vasoconstriction in young heavy smokers with normal coronary arteriographic findings. Am J Med. 1993;95:71-77.
35. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 1995; 92:1094-1100.
36. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133:144-153.
37. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:316-321.